RE:RE:RE:RE:RE:RE:RE:RE:the bashers are quiet today !! Ok, SZLS talks about two testing methods, since when do they have swabs? Do they have to acquire them? Then what? There's no clarity with this company. They put out a little taste test to get a bump in the price to make some money and then it will fall. It's a game. They won, they got 100% increase or so from the pre-news price. Why do you think there hasn't been an update on anything since??? They are allowed to provide details on partnering and planning and where they are in the process, unless, they have nothing. You don't need FDA or HC approval to discuss your plans, again, unless there is no plan. Then there is nothing to discuss.
PeerReviewed wrote: KPO is a subtle guy.
He's just silencing 4 majors events that differ from the past.
1) LIND conversion is complete
2) FDA's priority is antibody tests so they can know who can get back to work or not
3) FDA is sorting out the mess they've initially allowed in the antibody tests. With the help of the NCI now, antibody tests will have to be done under a CLIA-certified High Complexity lab to make sure tests are accurate.
4) SZLS is a CLIA-certified High Complexity lab.
Nice try.